Movement Alert｜INSILICO Falls 5.7% in Regular Trading, AI Drug Sector Pullback Triggers Profit-Taking

Market Focus

Oct 08

On October 8, INSILICO fell 5.7% in regular trading, trading at HK$49.98 with turnover of HK$298 million.

The decline was driven by a collective pullback in the AI drug sector after recent consecutive gains, prompting investors to lock in profits. A day earlier, the stock had already dropped 10.62%, while sector peer XTALPI fell 12.1%, reflecting broad-based selling across AI-driven innovative drug names.

Market analysis indicates that while AI-driven drug discovery remains a long-term industry trend, most companies are still in the pipeline validation stage, with long commercialization cycles and limited near-term cash flow. After rapid valuation expansion, profit-taking pressure has intensified. INSILICO operates an AI-powered drug discovery and pipeline development business through its proprietary Pharma.AI platform, with additional exposure to software solutions and non-pharmaceutical R&D.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1160404026"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1160404026\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1160404026?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-10-08 09:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1160404026","market":"hk","top_or_hot":-1,"title":"Movement Alert｜INSILICO Falls 5.7% in Regular Trading, AI Drug Sector Pullback Triggers Profit-Taking","media":"Market Focus","content":"<p><p>On October 8, INSILICO fell 5.7% in regular trading, trading at HK$49.98 with turnover of HK$298 million.</p><p>The decline was driven by a collective pullback in the AI drug sector after recent consecutive gains, prompting investors to lock in profits. A day earlier, the stock had already dropped 10.62%, while sector peer XTALPI fell 12.1%, reflecting broad-based selling across AI-driven innovative drug names.</p><p>Market analysis indicates that while AI-driven drug discovery remains a long-term industry trend, most companies are still in the pipeline validation stage, with long commercialization cycles and limited near-term cash flow. After rapid valuation expansion, profit-taking pressure has intensified. INSILICO operates an AI-powered drug discovery and pipeline development business through its proprietary Pharma.AI platform, with additional exposure to software solutions and non-pharmaceutical R&D.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜INSILICO Falls 5.7% in Regular Trading, AI Drug Sector Pullback Triggers Profit-Taking</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜INSILICO Falls 5.7% in Regular Trading, AI Drug Sector Pullback Triggers Profit-Taking\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-10-08 09:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On October 8, INSILICO fell 5.7% in regular trading, trading at HK$49.98 with turnover of HK$298 million.</p><p>The decline was driven by a collective pullback in the AI drug sector after recent consecutive gains, prompting investors to lock in profits. A day earlier, the stock had already dropped 10.62%, while sector peer XTALPI fell 12.1%, reflecting broad-based selling across AI-driven innovative drug names.</p><p>Market analysis indicates that while AI-driven drug discovery remains a long-term industry trend, most companies are still in the pipeline validation stage, with long commercialization cycles and limited near-term cash flow. After rapid valuation expansion, profit-taking pressure has intensified. INSILICO operates an AI-powered drug discovery and pipeline development business through its proprietary Pharma.AI platform, with additional exposure to software solutions and non-pharmaceutical R&D.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03696","symbol_name":"英矽智能","start_time":0,"source_url":"","article_id":"1160404026","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1160404026","pubTimestamp":1791423569,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On October 8, INSILICO fell 5.7% in regular trading, trading at HK$49.98 with turnover of HK$298 million.The decline was driven by a collective pullback in the AI drug sector after recent consecutive...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03696":"英矽智能"},"translate_title":"走势警报|INSILICO常规交易下跌5.7%，人工智能药物板块回调引发获利回吐","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03696":1},"content_text":"On October 8, INSILICO fell 5.7% in regular trading, trading at HK$49.98 with turnover of HK$298 million.The decline was driven by a collective pullback in the AI drug sector after recent consecutive gains, prompting investors to lock in profits. A day earlier, the stock had already dropped 10.62%, while sector peer XTALPI fell 12.1%, reflecting broad-based selling across AI-driven innovative drug names.Market analysis indicates that while AI-driven drug discovery remains a long-term industry trend, most companies are still in the pipeline validation stage, with long commercialization cycles and limited near-term cash flow. After rapid valuation expansion, profit-taking pressure has intensified. INSILICO operates an AI-powered drug discovery and pipeline development business through its proprietary Pharma.AI platform, with additional exposure to software solutions and non-pharmaceutical R&D.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}